BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3907969)

  • 1. Effect of norethisterone enanthate on the blood count and endometrial histology of Indian women.
    Chaudhuri C; Dutta SK; Mukherjea M
    Contraception; 1985 Oct; 32(4):417-28. PubMed ID: 3907969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
    Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
    Meng YX; Virutamasen P
    Contraception; 1991 Jul; 44(1):73-82. PubMed ID: 1893702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
    McEwan JA; Griffin M
    Contraception; 1991 Dec; 44(6):639-48. PubMed ID: 1773620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nor-ethisterone enanthate (SH 393) on the structure of the endometrium and on the cervical mucus.
    Achari K
    J Obstet Gynaecol India; 1969; 19(6):731-6. PubMed ID: 12255497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase IV study of the injection Norigest in Pakistan.
    Kazi A; Holck SE; Diethelm P
    Contraception; 1985 Oct; 32(4):395-403. PubMed ID: 3907968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
    Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG
    Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic changes in women using a monthly injectable contraceptive for one year.
    Meng YX; Jiang HY; Chen AJ; Lu FY; Yang H; Zhang MY; Shen KY; Sun DL; Shao QX; Fotherby K
    Contraception; 1990 Oct; 42(4):455-66. PubMed ID: 2124180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
    Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
    Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH; Parker RA; Diethelm P
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
    Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
    Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
    Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
    Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial vasculature in Norplant users.
    Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():45-50. PubMed ID: 8982745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.